Search Results - Hernberg, Micaela, MD

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial

    Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial by Hansson, Johan, Dr, Aamdal, Steinar, Prof, Bastholt, Lars, MD, Brandberg, Yvonne, Prof, Hernberg, Micaela, MD, Nilsson, Bo, MSc, Stierner, Ulrika, MD, von der Maase, Hans, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma

    Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma by Thiel, Alexandra, PhD, Moza, Monica, MD, PhD, Kytölä, Soili, PhD, Orpana, Arto, PhD, Jahkola, Tiina, MD, PhD, Hernberg, Micaela, MD, PhD, Virolainen, Susanna, MD, PhD, Ristimäki, Ari, MD, PhD

    Published in Human pathology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: